PANCREATIC CARCINOMA STAGE III

This adverse event was reported 701 times

These drugs are most commonly taken by patients reporting PANCREATIC CARCINOMA STAGE III:

# Drug Count
0 RANITIDINE 63
1 RANITIDINE HYDROCHLORIDE 20
2 PANCRELIPASE 6
3 SITAGLIPTIN 6
4 LIRAGLUTIDE 5
5 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 5
6 EXENATIDE 4
7 INSULIN GLARGINE 4
8 ADALIMUMAB 3
9 ASPIRIN 3
See all common drugs associated with PANCREATIC CARCINOMA STAGE III

PANCREATIC CARCINOMA STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 1 0.0008
1 RANITIDINE HYDROCHLORIDE 20 0.0004
2 RANITIDINE 63 0.0003
3 ROPINIROLE HYDROCHLORIDE 1 0.0003
4 NALOXEGOL OXALATE 1 0.0003
5 SILODOSIN 1 0.0002
6 SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 5 0.0002
7 PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE 1 0.0002
8 NABUMETONE 1 0.0002
9 PANCRELIPASE 6 0.0002
See all drugs enriched for association with PANCREATIC CARCINOMA STAGE III